Cargando…

P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING

Detalles Bibliográficos
Autores principales: Olschok, Kathrin, Altenburg, Bianca, de Toledo, Marcelo A.S., Maurer, Angela, Abels, Anne, Beier, Fabian, Gezer, Deniz, Isfort, Susanne, Brümmendorf, Tim H, Zenke, Martin, Chatain, Nicolas, Koschmieder, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431409/
http://dx.doi.org/10.1097/01.HS9.0000970936.66123.3c
_version_ 1785091193931038720
author Olschok, Kathrin
Altenburg, Bianca
de Toledo, Marcelo A.S.
Maurer, Angela
Abels, Anne
Beier, Fabian
Gezer, Deniz
Isfort, Susanne
Brümmendorf, Tim H
Zenke, Martin
Chatain, Nicolas
Koschmieder, Steffen
author_facet Olschok, Kathrin
Altenburg, Bianca
de Toledo, Marcelo A.S.
Maurer, Angela
Abels, Anne
Beier, Fabian
Gezer, Deniz
Isfort, Susanne
Brümmendorf, Tim H
Zenke, Martin
Chatain, Nicolas
Koschmieder, Steffen
author_sort Olschok, Kathrin
collection PubMed
description
format Online
Article
Text
id pubmed-10431409
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104314092023-08-17 P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING Olschok, Kathrin Altenburg, Bianca de Toledo, Marcelo A.S. Maurer, Angela Abels, Anne Beier, Fabian Gezer, Deniz Isfort, Susanne Brümmendorf, Tim H Zenke, Martin Chatain, Nicolas Koschmieder, Steffen Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431409/ http://dx.doi.org/10.1097/01.HS9.0000970936.66123.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Olschok, Kathrin
Altenburg, Bianca
de Toledo, Marcelo A.S.
Maurer, Angela
Abels, Anne
Beier, Fabian
Gezer, Deniz
Isfort, Susanne
Brümmendorf, Tim H
Zenke, Martin
Chatain, Nicolas
Koschmieder, Steffen
P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title_full P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title_fullStr P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title_full_unstemmed P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title_short P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
title_sort p1008: the telomerase inhibitor imetelstat differentially targets jak2v617f- versus calr-mutant myeloproliferative neoplasm cells and inhibits jak-stat signaling
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431409/
http://dx.doi.org/10.1097/01.HS9.0000970936.66123.3c
work_keys_str_mv AT olschokkathrin p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT altenburgbianca p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT detoledomarceloas p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT maurerangela p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT abelsanne p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT beierfabian p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT gezerdeniz p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT isfortsusanne p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT brummendorftimh p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT zenkemartin p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT chatainnicolas p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling
AT koschmiedersteffen p1008thetelomeraseinhibitorimetelstatdifferentiallytargetsjak2v617fversuscalrmutantmyeloproliferativeneoplasmcellsandinhibitsjakstatsignaling